Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase

被引:64
|
作者
Toth, Marietta [1 ]
Kun, Sandor [1 ]
Bokor, Eva [1 ]
Benltifa, Mahmoud [2 ,3 ,4 ]
Tallec, Gaylord [2 ,3 ,4 ]
Vidal, Sebastien [2 ,3 ,4 ]
Docsa, Tibor [5 ]
Gergely, Pal [6 ]
Somsak, Laszlo [1 ]
Praly, Jean-Pierre [2 ,3 ,4 ]
机构
[1] Univ Debrecen, Dept Organ Chem, H-4010 Debrecen, Hungary
[2] Univ Lyon, Inst Chim & Biochim Mol & Supramol, CNRS, Lab Chim Organ 2,UMR 5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] CPE Lyon, F-69616 Villeurbanne, France
[5] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Med Chem,Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[6] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
C-Glycosyl compounds; 1,3,4-Oxadiazoles; 1,2,4-Oxadiazoles; Glycogen phosphorylase; Inhibitors; TYPE-2; DIABETES-MELLITUS; 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES; ANTIDIABETIC AGENTS; EVOLVING EPIDEMIC; TARGETS; BINDING; MUSCLE; CYANIDES; THERAPY; AMIDES;
D O I
10.1016/j.bmc.2009.04.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of per-O-benzoylated 5-beta-D-glucopyranosyl-2-substituted-1,3,4-oxadiazoles was prepared by acylation of the corresponding 5-(beta-D-glucopyranosyl) tetrazole. As an alternative, oxidation of 2,6-anhydro-aldose benzoylhydrazones by iodobenzene I, I-diacetate afforded the same oxadiazoles. 1,3-Dipolar cycloaddition of nitrile oxides to per-O-benzoylated beta-D-glucopyranosyl cyanide gave the corresponding 5-beta-D-glucopyranosyl-3-substituted-1,2,4-oxadiazoles. The O-benzoyl protecting groups were removed by base-catalyzed transesterification. The 1,3,4-oxadiazoles were practically inefficient as inhibitors of rabbit muscle glycogen phosphorylase b while the 1,2,4-oxadiazoles displayed inhibitory activities in the micromolar range. The best inhibitors were the 5-beta-D-glucopyranosyl-3-(4-methylphenyl-and -2-naphthyl)- 1,2,4-oxadiazoles (K-i = 8.8 and 11.6 mu M, respectively). A detailed analysis of the structure-activity relationships is presented. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4773 / 4785
页数:13
相关论文
共 50 条
  • [21] Design, synthesis and structure-activity relationships of tetrahydroquinoline farnesyltransferase inhibitors.
    Lombardo, LJ
    Bhide, R
    Camuso, A
    Clark, J
    Fager, K
    Gullo-Brown, J
    Hunt, JT
    Inigo, I
    Kan, D
    Lee, F
    Manne, V
    McGlinchey, K
    Qian, LG
    Ricca, C
    Rovnyak, G
    Sheng, C
    Traeger, S
    Williams, D
    Wu, L
    Yang, J
    Zhao, YF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U174 - U175
  • [22] Synthesis and structure-activity relationships of tripeptide mimetic analogs of ACE inhibitors
    Liu, SF
    Xu, JC
    PEPTIDES: BIOLOGY AND CHEMISTRY, 1998, : 81 - 82
  • [23] Design, Synthesis, and Structure-Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors
    Ferlin, Maria Grazia
    Carta, Davide
    Bortolozzi, Roberta
    Ghodsi, Razieh
    Chimento, Adele
    Pezzi, Vincenzo
    Moro, Stefano
    Hanke, Nina
    Hartmann, Rolf W.
    Basso, Giuseppe
    Viola, Giampietro
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7536 - 7551
  • [24] Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β
    Tan, Kathrin
    Jaeger, Christian
    Geissler, Stefanie
    Schlenzig, Dagmar
    Buchholz, Mirko
    Ramsbeck, Daniel
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [25] Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D
    Bravo-Altamirano, Karla
    George, Kara M.
    Frantz, Marie-Celine
    LaValle, Courtney R.
    Tandon, Manuj
    Leimgruber, Stephanie
    Sharlow, Elizabeth R.
    Lazo, John S.
    Wang, Q. Jane
    Wipf, Peter
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (02): : 154 - 159
  • [26] Synthesis and structure-activity relationships of novel fungal chitin synthase inhibitors
    Masubuchi, K
    Taniguchi, M
    Umeda, I
    Hattori, K
    Suda, H
    Kohchi, Y
    Isshiki, Y
    Sakai, T
    Kohchi, M
    Shirai, M
    Okabe, H
    Sudoh, M
    Yamazaki, T
    Shimma, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) : 1459 - 1462
  • [27] Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors
    Marasini, Bishnu P.
    Rahim, Fazal
    Perveen, Shahnaz
    Karim, Aneela
    Khan, Khalid Mohammed
    Atta-ur-Rahman
    Choudhary, M. Iqbal
    BIOORGANIC CHEMISTRY, 2017, 70 : 210 - 221
  • [28] STRUCTURE-ACTIVITY RELATIONSHIPS IN ADENOSINE DEAMINASE INHIBITORS
    SCHAEFFE.HJ
    JOHNSON, RN
    ODIN, E
    HANSCH, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (03) : 452 - &
  • [29] Structure-activity relationships of adenosine deaminase inhibitors
    Vittori, S
    Camaioni, E
    Costanzi, S
    Volpini, R
    Lupidi, G
    Cristalli, G
    NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (4-5): : 741 - 742
  • [30] Structure-activity relationships in aminocyclopentitol glycosidase inhibitors
    Dickson, LG
    Leroy, E
    Reymond, JL
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (08) : 1217 - 1226